markedly altered podocyte foot processes, with decreased podocin expression, were observed histologically in 32-week-old Podo-Ogt y/À mice. Next, we induced adult-onset deletion of the Ogt gene in podocytes by TM injection in 8-week-old TM-Podo-Ogt y/À mice. In contrast to Podo-Ogt y/À mice, the induced TM-Podo-Ogt y/À mice did not develop albuminuria or podocyte damage, suggesting a need for O-GlcNAcylation to form mature foot processes after birth. To test this possibility, 3-week-old Podo-Ogt y/À mice were treated with Bis-T-23, which stimulates actin-dependent dynamin oligomerization, actin polymerization and subsequent foot process elongation in podocytes. Albuminuria and podocyte damage in 16-week-old Podo-Ogt y/À mice were prevented by Bis-T-23 treatment. Conclusions. O-GlcNAcylation is necessary for maturation of podocyte foot processes, particularly after birth. Our study provided new insights into podocyte biology and OGlcNAcylation.
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I N T R O D U C T I O N
Podocytes are terminally differentiated cells, unable to regenerate. They consist of a cell body and primary and secondary foot processes. Secondary foot processes form a zipper-like structure with adjacent podocytes. This unique structure and podocyte survival are essential to maintain the glomerular filtration barrier function and protect against macromolecule leakage into urine from blood [1, 2] . A number of cellular mechanisms and signal transduction systems regulate podocyte biology [1, 2] . Thus, studies aimed at identifying the novel regulatory mechanisms underlying podocyte function and survival should contribute to the understanding of podocyte biology and increase understanding of proteinuric kidney diseases.
Most cellular functions are regulated mainly by the central dogma that 'DNA makes RNA that makes protein' [3] . However, protein post-translational modifications, such as phosphorylation, acetylation, methylation, ubiquitination and sumoylation, are also key regulators of protein function and, as a result, cellular function [4] [5] [6] [7] . Furthermore, studies showed that many of these modifications are involved in regulating podocyte function and their alterations are associated with the pathogenesis of proteinuric kidney diseases [8] [9] [10] [11] . Thus, protein post-translational modifications are potential experimental targets for understanding podocyte biology and treating kidney diseases.
There has been recent focus on O-linked b-N-acetylglucosamine modification (O-GlcNAcylation) of intracellular proteins, another type of post-translational modification [12, 13] . UDP-GlcNAc, the substrate for O-GlcNAcylation, is produced via the hexosamine pathway, a branch of glycolysis. The O-GlcNAcylation reaction is the addition of GlcNAc to serine or threonine residues of proteins and is regulated by two enzymes. O-GlcNAc transferase (Ogt) transfers the GlcNAc moiety from the donor UDP-GlcNAc to substrate proteins and O-GlcNAcase (OGA) hydrolyzes O-GlcNAc from proteins [12] [13] [14] . Several recent studies using tissue-specific Ogt-deficient mice demonstrated that O-GlcNAcylation has a wide range of physiological effects in metabolic tissues such as liver, brain and pancreas. Because of its relationship to metabolic diseases, O-GlcNAcylation is considered a new potential therapeutic target for these diseases [15] [16] [17] [18] .
The active hexosamine pathway and subsequent Ogtmediated protein O-GlcNAcylation play pathological roles in high dietary sucrose-induced dysfunction in the 'Drosophila' nephrocyte, a cell type analogous to the mammalian podocyte [19] . Furthermore, approximately 1000 O-GlcNAcylated proteins were detected in rat kidneys [20] . Some of these proteins were predominantly expressed in podocytes, and their levels increased in diabetic kidneys [20] . Most important, OGlcNAcylation was observed in human glomerular cells [21] . Therefore, this protein modification is abundant and appears to occur in response to a nutrient change in podocytes, across species, implicating it in the pathogenesis of human kidney diseases such as diabetic nephropathy. However, little is known about the physiological significance of O-GlcNAcylation in normal mammalian kidney development and function.
We hypothesized that investigating the physiological effects of O-GlcNAcylation in podocytes would provide novel insights into podocyte biology and mechanisms of kidney diseases, particularly those associated with metabolic disorders. Thus, in our study, we analyzed the renal phenotypes of congenital and tamoxifen (TM)-induced podocyte-specific Ogt knockout mice to investigate the importance of O-GlcNAcylation in podocytes.
M A T E R I A L S A N D M E T H O D S

Ethics
All animal handling and experimentation were conducted according to the guidelines of the Research Center for Animal Life Science at Shiga University of Medical Science. All experimental protocols were approved by the Gene Recombination Experiment Safety Committee and the Research Center for Animal Life Science at Shiga University of Medical Science.
Generation of congenital podocyte-specific Ogt knockout mice
Tissue-specific Ogt-deficient mice were generated using the Cre-loxP system. Male podocyte-specific Ogt knockout (Pod-Ogt y/À ) and female podocyte-specific Ogt knockout (PodOgt À/À ) mice were generated by crossbreeding Ogt-flox mice [22] with Nphs2-Cre transgenic mice [23] . Specific expression of Cre recombinase in podocytes was confirmed by further crossbreeding with td-Tomato reporter mice. Control and knockout mice received a standard diet for up to 32 weeks and then the degree of albuminuria was assessed. Mice were sacrificed at 8, 16 and 32 weeks of age for renal histological assessments. Each group included at least four mice.
Bis-T-23 treatment
Bis-T-23 (Aberjona Laboratories, Inc., Beverly, MA, USA) was prepared as a 30 mM stock solution in dimethyl sulfoxide (DMSO) and stored frozen. The required amounts were added to phosphate-buffered saline (PBS) with final DMSO concentrations of 1% or less [24] . DMSO in PBS was used as the vehicle control. Pod-Ogt y/À mice were subjected to the vehicle or Bis-T-23 (20 mg/kg) from 3 to 6 weeks of age [24] . Pod-Ogt y/À mice treated with vehicle were used as the control group. Each group included at least four mice.
Generation of TM-inducible podocyte-specific Ogt knockout mice TM-inducible podocyte-specific Ogt knockout (TM-PodOgt y/À ) mice were generated by crossbreeding Ogt-flox mice with Nphs2-CreER T2 transgenic mice [25] . Ogt deletion was induced by TM injection (150 mg/kg/day) for five consecutive days, beginning at 8 weeks of age. Effectiveness of TMinduced Cre recombinase expression in podocytes was confirmed by crossbreeding with td-Tomato-reporter mice. Control TM-Pod-Ogt y/f (n ¼ 5) and TM-Pod-Ogt y/À mice (n ¼ 5) received a standard diet for 32 weeks after the induction and then albuminuria was assessed. After sacrifice, renal histological changes were also assessed.
Blood and urinary analyses
Blood glucose concentrations were measured using a Glutest sensor (Sanwa Kagaku, Nagoya, Japan). Urinary albumin excretion was measured by sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel electrophoresis followed by Coomassie brilliant blue staining and also by the Mikrofluoral Microalbumin Test (PROGEN, Heidelberg, Germany) [26] . Urinary creatinine was measured by the LabAssay Creatinine assay kit (Wako, Osaka, Japan). Urinary albumin excretion levels were expressed as albumin to creatinine ratios in the urine.
Histological analysis
Fixed kidney samples, either frozen or embedded in paraffin, were sectioned at 3 lm thickness. Periodic acid-Schiff (PAS) staining, hematoxylin and eosin (HE) staining, immunohistochemistry and immunofluorescence were performed as described previously [26] . Antibodies against F4/80 (Serotec, Oxford, UK), Wilms's tumor 1 (WT1) (Santa Cruz Biotechnology, CA, USA), podocin (Sigma, St Louis, MO, USA) and RL2 (Abcam, Cambridge, MA, USA) were used for immunohistochemistry and immunofluorescence. Transmission and scanning electron microscopy (EM) analyses were performed with Hitachi S-570 and H-7500 instruments, respectively (Hitachi, Tokyo, Japan). To determine podocyte number, serial kidney sections were stained with WT1 antibody and WT1-positive cells counted, with the number calculated using the dissector/fractionator combination method [26] . Histological analyses were performed by three independent nephrologists in a blinded manner.
Statistical analysis
Results are expressed as means 6 standard error of the mean (SEM). Analysis of variance and a post hoc Tukey's test were used to determine significant differences for multiple comparisons. The Student's t-test was used for comparisons between two groups. A P < 0.05 was considered to be statistically significant.
R E S U L T S Protein O-GlcNAcylation in podocytes
In the kidney frozen sections, immunofluorescence staining for O-GlcNAc (using the RL2 antibody) showed staining in Wilms' tumor protein (WT1)-positive podocytes in normal C57BL/6J mice ( Figure 1A) . O-GlcNAc staining in podocytes was increased after an intraperitoneal glucose injection, suggesting that protein O-GlcNAcylation can be affected by changes in nutrient status ( Figure 1A ).
Generation of congenital podocyte-specific Ogt knockout (Pod-Ogt y/À ) mice
We first generated male congenital Pod-Ogt y/À mice by crossbreeding Ogt-flox mice with podocyte-specific Cre mice ( Figure 1B ). Specific Cre recombinase expression in podocytes was confirmed by crossbreeding with td-Tomato-reporter mice ( Figure 1C ).
In control Ogt y/f mice, RL2 staining indicated that protein O-GlcNAcylation was co-localized with WT1, a podocytespecific nuclear protein ( Figure 1D ), while it did not overlap with podocin staining ( Figure 1E ). These results indicated that protein O-GlcNAcylation was specific to intracellular, not slit diaphragm, proteins. Furthermore, in Pod-Ogt y/À mice, there was no RL2 staining in WT1-positive podocytes ( Figure 1D ). Thus, the Pod-Ogt y/À mice were suitable for investigating physiological roles of O-GlcNAcylation in podocytes.
Age-dependent podocyte damage in congenital PodOgt y/À mice Pod-Ogt y/À mice showed normal growth patterns and glucose metabolism, compared with control Ogt y/f mice ( Figure 1F and G). However, in Pod-Ogt y/À mice, urinary albumin excretion appeared at 8 weeks and markedly increased over time, up to 32 weeks of age (Figure 2A and B). Histologically, glomerular sclerotic changes, protein casts and tubular dilatation were observed by PAS staining in the kidneys of 32-week-old PodOgt y/À mice ( Figure 2C ). These features were accompanied by proteinuria and subsequent tubular cell damage and increased cellular infiltrates, detected by HE staining, as well as F4/80-positive macrophages ( Figure 2D ).
Podocin expression was decreased after 8 weeks of age in Pod-Ogt y/À mice and its staining pattern became more granular and irregularly scattered with subsequent aging ( Figure 3A) . By scanning EM, the zipper-like structure of secondary foot processes in podocytes was degraded in Pod-Ogt y/À mice at 8 weeks of age, an effect that worsened with time ( Figure 3B ). Finally, secondary foot processes were not detectable in 32-week-old Pod-Ogt y/À mice ( Figure 3B ). Consistent with this, flattening and effacement of podocyte foot processes were observed by transmission EM in these mice after 8 weeks of age ( Figure 3C ). Based on WT1-positive cells, podocyte numbers were ). Like the males, 32-week-old female Pod-Ogt À/À mice developed proteinuria ( Figure 4A and B) and podocyte damage that was characterized by an irregular pattern of podocin expression and altered foot process structure ( Figure 4C and D) . Thus, podocyte-specific deletion of the Ogt gene caused podocyte dysfunction, irrespective of sex.
Generation of acquired podocyte-specific Ogt knockout mice
Because congenital Ogt deletion in podocytes led to severe renal phenotypes in mice, we next used conditional knockout mice to examine Ogt-mediated protein O-GlcNAcylation in adults. We generated TM-induced podocyte-specific Ogt knockout (TM-Pod-Ogt y/À ) mice and treated them with TM at 8 weeks of age ( Figure 5A ). TM-induced Cre recombinase expression in podocytes was confirmed by crossbreeding with tdTomato-reporter mice ( Figure 5B). Compared with control mice, we found an approximately 90% decrease in podocytes staining for O-GlcNAcylation at 2 weeks after TM injection in TM-Pod-Ogt y/À mice. This was determined by double staining for WT1 and RL2 ( Figure 5C and D) .
Mild renal phenotype in TM-Pod-Ogt y/À mice Control Ogt y/f and TM-Pod-Ogt y/À mice did not differ in metabolic phenotype during the entire 32 weeks after TM injection (data not shown). Unexpectedly, in contrast to the congenital Pod-Ogt y/À mice, TM-Pod-Ogt y/À mice did not have increased albuminuria, even at 32 weeks after TM injection ( Figure 5E ). Furthermore, there were no significant glomerular changes observed by either HE or PAS staining. Relative to control mice, there was no podocyte loss nor alterations of podocin expression in kidneys of TM-Pod-Ogt y/À mice ( Figure 5F -I), although some foot process alterations were evident by scanning and transmission EM ( Figure 5J ).
There is growing evidence that, during development of glomerular injury, podocyte repopulation from other renal cell types, such as parietal epithelial cells and other extraglomerular sources, can compensate for loss of the original podocytes [27] [28] [29] [30] . Because TM was injected only once, at 8 weeks of age, in TM-Pod-Ogt y/À mice, damaged podocytes might have been replaced by other renal cells with normal O-GlcNAcylation, leading to a mild renal phenotype in TM-Pod-Ogt y/À mice. To rule out this possibility, we performed double immunofluorescence staining for RL2 and WT1 in kidneys from control and TM-Pod-Ogt y/À mice, harvested at 32 weeks after TM injection. Most WT1-positive podocytes were also negative for Figure 5C and D) . In TM-PodOgt y/À mice, there were only a small number of cells staining for both WT1 and RL2, indicating few repopulated cells, at 32 weeks after TM injection. This number was not significantly greater than that observed at 2 weeks after injection ( Figure 5C and D). These results suggested that podocyte repopulation was not the explanation for the mild renal phenotype of TM-PodOgt y/À mice. Thus, adult-onset deletion of O-GlcNAcylation did not affect normal podocyte function.
Preventive effects of Bis-T-23 treatment in congenital Pod-Ogt y/À mice
Because podocytes cannot replicate, while glomerular size increases with body growth after birth, podocytes are believed to elongate their foot processes within about 2 weeks after birth. In fact, in mice examined just after birth, our scanning EM results indicated that foot process features were immature ( Figure 6A ) and there was no podocin expression inside glomeruli ( Figure  6B ), even in control Ogt y/f mice, while podocytes were completely mature by 8 weeks of age ( Figure 3A-C) . Furthermore, control Ogt y/f and Pod-Ogt y/À mice showed no apparent differences in podocyte morphology at birth (Figure 6A and B) . We thus hypothesized that absence of O-GlcNAcylation impaired podocyte foot process maturation occurring within 8 weeks, resulting in significantly different renal phenotypes in Pod-Ogt y/À and TM-Pod-Ogt y/À mice. Regardless of whether it is caused by genetics or disease, podocyte injury leads to reorganization of the actin cytoskeleton, which underlies the loss of actin-based foot processes, a phenomenon referred to as foot process effacement [2] . A recent study showed that actin-dependent dynamin oligomerization was essential for maintaining foot processes across species and that Bis-T-23, a small molecule, stimulated this process, promoting foot process elongation in podocytes and preventing subsequent proteinuria in mouse disease models and even in mice with genetically engineered podocyte injury [24] . Therefore, we tested our hypothesis by examining effects of Bis-T-23 on foot process maturation, after birth, in Pod-Ogt y/À mice. We treated 3-week-old Pod-Ogt y/À mice with Bis-T-23 for 3 weeks, then analyzed their renal phenotypes at 16 weeks of age ( Figure 6C ).
Albuminuria in 16-week-old Podo-Ogt y/À mice was prevented by the Bis-T-23 treatment ( Figure 6D and E) . Furthermore, alterations in foot process formation and loss of Figure 6F ). These results supported our hypothesis that O-GlcNAcylation is involved in podocyte maturation after birth.
D I S C U S S I O N
Because O-GlcNAcylation acts as a nutrient-sensing signal to regulate a variety of cellular functions, research on this protein modification process in mammals is rapidly advancing [12, 13, [15] [16] [17] [18] . In particular, the roles of O-GlcNAcylation in some mammalian tissues, such as pancreatic b cells, liver, heart and brain, are under extensive study [12, [16] [17] [18] . However, no reports, to date, have addressed potential functions of OGlcNAcylation in the kidney. Our results, therefore, should provide novel insights into both O-GlcNAcylation and podocyte biology.
Only a few reports have described O-GlcNAcylation in podocytes. We found that proteins modified by O-GlcNAcylation were localized to the cytosol and nucleus, but not to slit membranes of podocyte foot processes. Thus, similar to its role in other mammalian cells, O-GlcNAcylation likely regulates cellular processes in podocytes by affecting intracellular and/or intranuclear proteins.
Our data indicated that O-GlcNAcylation is essential for normal podocyte development after birth. Consistent with our findings in podocytes, congenital cardiomyocyte-specific Ogt deletion in mice impaired maturation of the heart, leading to severe heart failure, whereas an inducible deletion of Ogt in adult mice did not cause overt cardiac dysfunction [31] . Furthermore, pancreatic b cell-specific Ogt knockout mice developed b cell death, leading to hypoinsulinemic hyperglycemia [17] . In addition, enhanced endoplasmic reticulum (ER) stress was associated with organ dysfunction in both the cardiac and pancreatic models, although the detailed molecular interactions between Ogt deletion and ER stress were not addressed [17, 31] . In some disease models, ER stress was linked to pathogenesis of podocyte injury [32] . Overall, Ogt-mediated O-GlcNAcylation may be essential for normal development of any mammalian organ, not just podocytes. Moreover, ER stress might be involved in podocyte injury in podocyte-specific Ogt knockout mice, although this was not addressed in our study.
Our study demonstrated that Ogt-mediated O-GlcNAcylation was essential for complete maturation of podocyte foot processes in mice ( Figure 7A and B) . However, the absence of this modification did not affect podocyte number or morphology immediately after birth, suggesting that GlcNAcylation is not involved in podocyte development at the embryonic stage. Furthermore, the absence of O-GlcNAcylation did not affect the function of mature podocytes. The different renal phenotypes in congenital and acquired Pod-Ogt y/À mice was, therefore, an interesting finding in our study. Because Bis-T-23 treatment prevented podocyte damage in Pod-Ogt y/À mice, it was likely that O-GlcNAcylation was involved in the cellular mechanisms of actin polymerization and subsequent foot process elongation, making it essential for complete maturation of podocytes after birth ( Figure 7C and D) .
Diabetic nephropathy is an important field for study of OGlcNAcylation, because the substrate for this modification is an end product of the hexosamine pathway, a branch of glycolysis. In fact, compared with control subjects, O-GlcNAcylation was increased in renal cells from patients with diabetic nephropathy [21] . Suppression of O-GlcNAcylation was proposed as a novel potential therapy for the disease [33] . Thus, O-GlcNAcylation causes a gain-of-function that is likely to be associated with the pathogenesis of diabetic nephropathy [33] . In contrast, the clinical significance of the loss-of-function caused by O-GlcNAcylation is not yet strongly supported. Because we observed that O-GlcNAcylation was needed for foot process elongation during normal development after birth, it may also be required to elongate foot processes in response to certain diseases associated with glomerular hypertrophy. Accordingly, the loss-of-function may be important for pathogenesis of hyperfiltration-related proteinuria. Therefore, excess inhibition of O-GlcNAcylation may worsen diabetic nephropathy, a Our study highlighted other issues that remain unresolved. First, the target proteins for O-GlcNAcylation contributing to the phenotype of Pod-Ogt y/À mice are unknown. A previous report identified some cytoskeletal proteins, such as a-actin and a-actinin 4, with altered expression in the podocytes of diabetic kidneys, as candidates for the modification [20] . In both mice and humans, a loss-of-function mutation in the a-actinin 4 gene (ACTN4) is involved in podocyte dysfunction in focal segmental glomerulosclerosis [34, 35] . Interestingly, Bis-T-23 [24, 35] . Because Bis-T-23 treatment ameliorated foot process effacement in PodOgt y/À mice, deficient O-GlcNAcylation to these cytoskeletal proteins, particularly a-actinin 4, might have been involved in impaired foot process maturation in Pod-Ogt y/À mice. However, about 1000 proteins were found to undergo O-GlcNAcylation [20] , so other protein targets might also have explained our observations. Identification of specific proteins modified by O-GlcNAcylation and their relationships with podocyte function might increase understanding of podocyte biology and the pathogenesis of kidney diseases.
Second, it is still unclear whether podocyte loss, after 16 weeks of age, in Pod-Ogt y/À mice was directly caused by deficient OGlcNAcylation or, instead, by a secondary event related to foot process dysfunction. A recent study showed that urinary proteinuria itself caused podocyte damage and loss, further enhancing proteinuria in a vicious cycle [36] . These findings suggested that further study is needed. Finally, although we focused on OGlcNAcylation in podocytes, we also observed this protein modification in other renal cell types, including parietal epithelial and proximal tubular cells. These modifications were also enhanced in response to a glucose challenge. Both cell types are involved in the pathogenesis of various kidney diseases. In particular, parietal epithelial cells were identified as podocyte progenitors [28] [29] [30] . Thus, O-GlcNAcylation might have important physiological functions, including in podocyte repair, as a nutrient sensor in these other cell types. Future studies designed to identify the exact role of this modification in these kidney cells may further elucidate renal physiology and the pathogenesis of kidney diseases such as diabetic nephropathy.
In conclusion, our data indicated that Ogt-mediated O-GlcNAcylation is essential for normal podocyte maturation, particularly after birth. These results provided novel insights into podocyte biology, contributing to an increased understanding of podocyte damage in proteinuric kidney diseases. 
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